Skip to content

Clinical trials

Phase 3 Hypertension trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Phase: Phase 3 Country / region: Netherlands Clear all

46 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20031
20041
20052
20065
20071
20083
20093
20101
20113
20121
20133
20142
20171
20184
20193
20201
20211
20221
20233
20241
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed35
Terminated5
Recruiting3
Active, not recruiting2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
AstraZeneca4
Takeda4
Novartis3
Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA2
GlaxoSmithKline2
Mineralys Therapeutics Inc.2
ROX Medical, Inc.2
The George Institute2
UMC Utrecht2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension46
Cardiovascular Diseases7
Diabetes Mellitus, Type 25
Pulmonary Arterial Hypertension4
Renal Insufficiency, Chronic4
Vascular Diseases4
Essential Hypertension3
Atherosclerosis2
Cerebral Hemorrhage2
Cerebral Small Vessel Diseases2

Trials

Showing 1 to 25 of 46. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.